Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1991 1
1992 1
1993 4
1994 19
1995 8
1996 14
1997 14
1998 26
1999 14
2000 22
2001 30
2002 26
2003 56
2004 39
2005 60
2006 54
2007 85
2008 123
2009 134
2010 155
2011 217
2012 276
2013 298
2014 393
2015 427
2016 430
2017 434
2018 419
2019 388
2020 400
2021 405
2022 336
2023 294
2024 296
2025 334
2026 221

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,397 results

Results by year

Filters applied: . Clear all
Page 1
Active surveillance for intermediate-risk prostate cancer.
Nayan M, Carvalho FLF, Feldman AS. Nayan M, et al. World J Urol. 2022 Jan;40(1):79-86. doi: 10.1007/s00345-021-03893-1. Epub 2022 Jan 19. World J Urol. 2022. PMID: 35044491 Review.
INTRODUCTION: Active surveillance (AS) is an established approach in the management of low-risk, localized prostate cancer. ...Further research is needed to identify select patients with IR prostate cancer that can be managed safely with …
INTRODUCTION: Active surveillance (AS) is an established approach in the management of low-risk, localized prostate …
Active surveillance for prostate cancer: selection criteria, guidelines, and outcomes.
Walker CH, Marchetti KA, Singhal U, Morgan TM. Walker CH, et al. World J Urol. 2022 Jan;40(1):35-42. doi: 10.1007/s00345-021-03622-8. Epub 2021 Mar 2. World J Urol. 2022. PMID: 33655428 Review.
INTRODUCTION: Active surveillance (AS) has been widely adopted for the management of men with low-risk prostate cancer. ...CONCLUSION: While AS is a safe and increasingly utilized treatment modality for lower-risk forms of PCa, ongoing research is need …
INTRODUCTION: Active surveillance (AS) has been widely adopted for the management of men with low-risk prostate canc …
Active surveillance in intermediate-risk prostate cancer.
Klotz L. Klotz L. BJU Int. 2020 Mar;125(3):346-354. doi: 10.1111/bju.14935. Epub 2020 Jan 16. BJU Int. 2020. PMID: 31647166 Review.
OBJECTIVES: Active surveillance (AS), now the standard of care for most men with favourable-risk prostate cancer, is appealing for selected men with 'favourable' intermediate-risk prostate cancer. ...RESULTS: Candidates are those patients …
OBJECTIVES: Active surveillance (AS), now the standard of care for most men with favourable-risk prostate cancer …
Active Surveillance for Prostate Cancer.
Klotz L. Klotz L. Urol Clin North Am. 2026 Feb;53(1):99-113. doi: 10.1016/j.ucl.2025.09.009. Urol Clin North Am. 2026. PMID: 41266006 Review.
Active surveillance (AS), first described as a management strategy for favorable risk prostate cancer more than 20 years ago has now been widely adopted as the treatment of choice for these patients. AS surveillance initially consisted of regula …
Active surveillance (AS), first described as a management strategy for favorable risk prostate cancer more than …
Modern Active Surveillance in Prostate Cancer: A Narrative Review.
Pattenden TA, Samaranayke D, Morton A, Ong WL, Murphy DG, Pritchard E, Evans S, Millar J, Chalasani V, Rashid P, Winter M, Vela I, Pryor D, Mark S, Lawrentschuk N, Thangasamy IA. Pattenden TA, et al. Clin Genitourin Cancer. 2023 Feb;21(1):115-123. doi: 10.1016/j.clgc.2022.09.003. Epub 2022 Sep 8. Clin Genitourin Cancer. 2023. PMID: 36443163 Review.
The use of PSA screening has led to downstaging and downgrading of prostate cancer at diagnosis, increasing detection of indolent disease. Active surveillance aims to reduce over-treatment by delaying or avoiding radical treatment and its associated mo …
The use of PSA screening has led to downstaging and downgrading of prostate cancer at diagnosis, increasing detection of indol …
Active Surveillance for Prostate Cancer in Older Men.
McLeay MT 2nd, Parker WP. McLeay MT 2nd, et al. Clin Geriatr Med. 2025 May;41(2):187-196. doi: 10.1016/j.cger.2025.01.004. Epub 2025 Mar 10. Clin Geriatr Med. 2025. PMID: 40345773 Review.
Prostate cancer is a common disease, affecting 1 in 8 men. The risk of mortality from untreated prostate cancer is limited in the first 5 to 10 years after treatment and as a result, the benefit of treatment is in men with greater than 10 years of life …
Prostate cancer is a common disease, affecting 1 in 8 men. The risk of mortality from untreated prostate cancer …
Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice.
Pastor-Navarro B, Rubio-Briones J, Borque-Fernando Á, Esteban LM, Dominguez-Escrig JL, López-Guerrero JA. Pastor-Navarro B, et al. Int J Mol Sci. 2021 Jun 10;22(12):6266. doi: 10.3390/ijms22126266. Int J Mol Sci. 2021. PMID: 34200878 Free PMC article. Review.
Prostate cancer (PCa) is the most commonly diagnosed cancer in men. The diagnosis is currently based on PSA levels, which are associated with overdiagnosis and overtreatment. Moreover, most PCas are localized tumours; hence, many patients with low-/very low-r …
Prostate cancer (PCa) is the most commonly diagnosed cancer in men. The diagnosis is currently based on PSA levels, whi …
Active surveillance for prostate cancer.
Romero-Otero J, García-Gómez B, Duarte-Ojeda JM, Rodríguez-Antolín A, Vilaseca A, Carlsson SV, Touijer KA. Romero-Otero J, et al. Int J Urol. 2016 Mar;23(3):211-8. doi: 10.1111/iju.13016. Epub 2015 Nov 30. Int J Urol. 2016. PMID: 26621054 Free PMC article.
It is worth distinguishing between the two strategies of expectant management for prostate cancer. Watchful waiting entails administering non-curative androgen deprivation therapy to patients on development of symptomatic progression, whereas active …
It is worth distinguishing between the two strategies of expectant management for prostate cancer. Watchful waiting …
Evidence-based approach to active surveillance of prostate cancer.
Witherspoon L, Breau RH, Lavallée LT. Witherspoon L, et al. World J Urol. 2020 Mar;38(3):555-562. doi: 10.1007/s00345-019-02662-5. Epub 2019 Feb 6. World J Urol. 2020. PMID: 30726506 Review.
Active surveillance is a good management option for some men with non-metastatic prostate cancer. In this review, we examine the evidence for several topics related to active surveillance. We examine: (1) which patients should be eligible …
Active surveillance is a good management option for some men with non-metastatic prostate cancer. In this review …
Active Surveillance for Prostate Cancer: Expanding the Role of MR Imaging and the Use of PRECISE Criteria.
Englman C, Barrett T, Moore CM, Giganti F. Englman C, et al. Radiol Clin North Am. 2024 Jan;62(1):69-92. doi: 10.1016/j.rcl.2023.06.009. Epub 2023 Aug 21. Radiol Clin North Am. 2024. PMID: 37973246 Review.
Multiparametric magnetic resonance (MR) imaging has had an expanding role in active surveillance (AS) for prostate cancer. It can improve the accuracy of prostate biopsies, assist in patient selection, and help monitor cancer progression. …
Multiparametric magnetic resonance (MR) imaging has had an expanding role in active surveillance (AS) for prostate c …
5,397 results